{"id":15925,"date":"2026-06-18T11:31:43","date_gmt":"2026-06-18T11:31:43","guid":{"rendered":"https:\/\/siliconvalleymovingpost.com\/?p=15925"},"modified":"2026-06-18T11:31:43","modified_gmt":"2026-06-18T11:31:43","slug":"fda-panel-considers-a-first-of-its-kind-flu-vaccine-using-mrna-technology","status":"publish","type":"post","link":"https:\/\/siliconvalleymovingpost.com\/?p=15925","title":{"rendered":"FDA panel considers a first-of-its-kind flu vaccine using mRNA technology"},"content":{"rendered":"
\n

By LAURAN NEERGAARD and MATTHEW PERRONE<\/strong><\/p>\n

WASHINGTON (AP) \u2014 U.S. health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic.<\/p>\n

Read more Who\u2019s playing in the World Cup today? TV schedule for June 18<\/a><\/p>\n

Moderna is seeking Food and Drug Administration approval of its new shot, dubbed mFlusiva, as an option for people 50 and older. The FDA advisory committee meeting is a step toward a final decision ahead of the winter flu season.<\/p>\n

Tens of thousands of Americans die from influenza every year, and older adults are among the most vulnerable. There are various types of flu vaccines already available in the U.S., including three specifically recommended for people 65 and older. But vaccines made with the Nobel Prize-winning mRNA technology are faster to manufacture than other types \u2014 something experts say might help if the shape-shifting flu virus mutates in a way that requires suddenly brewing new doses to match.<\/p>\n

In a study of 40,000 people age 50 and older, Moderna\u2019s mRNA vaccine reduced flu cases by about 27% compared to those given another routinely used vaccine brand. Ahead of the meeting, FDA published a favorable review of that data and reported no safety concerns.<\/p>\n

Moderna is seeking full approval for the vaccine\u2019s use in the 50- to 64-year-old population \u2014 along with authorization for use in those 65 and older while it conducts additional testing.<\/p>\n

Earlier this year, Moderna\u2019s data was at the center of a highly unusual public dispute as a then-top FDA official blocked the company\u2019s application for its first-of-its-kind shot.<\/p>\n

Read more World Cup: Luis D\u00edaz sparks Colombia past Uzbekistan<\/a><\/p>\n

The embattled vaccine chief at the time, Dr. Vinay Prasad, said the company should have compared its shot to a high-dose flu vaccine recommended for seniors rather than a standard-dose brand. It was a sign of FDA\u2019s heightened vaccine scrutiny under Health Secretary Robert F. Kennedy Jr.<\/p>\n

\n<\/div>\n

Moderna challenged that decision, noting that FDA staff had approved that main study\u2019s design and citing a separate, smaller study comparing the mRNA shot with a high-dose vaccine for seniors. Days after the spat, the FDA accepted Moderna\u2019s application.<\/p>\n

The expert panel also will assess that smaller study, which found Moderna\u2019s shot generated flu-fighting antibodies similarly to a high-dose senior shot. The FDA\u2019s initial review noted the new vaccine lacks data on very frail older adults and those with weak immune systems.<\/p>\n

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute\u2019s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.<\/em><\/p>\n

Read more Depleted Sparks can\u2019t keep pace with Olivia Miles, 1st-place Lynx<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Moderna seeks FDA approval for a new flu vaccine that is made with the same mRNA technology that was key to ending the COVID-19 pandemic.<\/p>\n","protected":false},"author":1,"featured_media":15924,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43,2],"tags":[],"class_list":["post-15925","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-based-on-facts-either-observed-and-verified-directly-by-the-reporter-or-reported-and-verified-from-knowledgeable-sources","category-news"],"yoast_head":"\nFDA panel considers a first-of-its-kind flu vaccine using mRNA technology - Silicon Valley Moving Post<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/siliconvalleymovingpost.com\/?p=15925\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA panel considers a first-of-its-kind flu vaccine using mRNA technology - Silicon Valley Moving Post\" \/>\n<meta property=\"og:description\" content=\"Moderna seeks FDA approval for a new flu vaccine that is made with the same mRNA technology that was key to ending the COVID-19 pandemic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/siliconvalleymovingpost.com\/?p=15925\" \/>\n<meta property=\"og:site_name\" content=\"Silicon Valley Moving Post\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-18T11:31:43+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?p=15925#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?p=15925\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/#\\\/schema\\\/person\\\/636e2e5a10a21cf87fe6eb5951e8a6b7\"},\"headline\":\"FDA panel considers a first-of-its-kind flu vaccine using mRNA technology\",\"datePublished\":\"2026-06-18T11:31:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?p=15925\"},\"wordCount\":472,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?p=15925#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/96774d3c8a0e0efe3cdbd668c8793d55.webp\",\"articleSection\":[\"Based on facts, either observed and verified directly by the reporter, or reported and verified from knowledgeable sources.\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?p=15925#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?p=15925\",\"url\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?p=15925\",\"name\":\"FDA panel considers a first-of-its-kind flu vaccine using mRNA technology - Silicon Valley Moving Post\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?p=15925#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?p=15925#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/96774d3c8a0e0efe3cdbd668c8793d55.webp\",\"datePublished\":\"2026-06-18T11:31:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/#\\\/schema\\\/person\\\/636e2e5a10a21cf87fe6eb5951e8a6b7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?p=15925#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?p=15925\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?p=15925#primaryimage\",\"url\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/96774d3c8a0e0efe3cdbd668c8793d55.webp\",\"contentUrl\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/96774d3c8a0e0efe3cdbd668c8793d55.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?p=15925#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA panel considers a first-of-its-kind flu vaccine using mRNA technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/#website\",\"url\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/\",\"name\":\"Silicon Valley Moving Post\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/#\\\/schema\\\/person\\\/636e2e5a10a21cf87fe6eb5951e8a6b7\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/50b1ad2e498f523425ee0a8cc5180a210646db1622662a3d56cc405d3e0c346a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/50b1ad2e498f523425ee0a8cc5180a210646db1622662a3d56cc405d3e0c346a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/50b1ad2e498f523425ee0a8cc5180a210646db1622662a3d56cc405d3e0c346a?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"http:\\\/\\\/siliconvalleymovingpost.com\"],\"url\":\"https:\\\/\\\/siliconvalleymovingpost.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA panel considers a first-of-its-kind flu vaccine using mRNA technology - Silicon Valley Moving Post","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/siliconvalleymovingpost.com\/?p=15925","og_locale":"en_US","og_type":"article","og_title":"FDA panel considers a first-of-its-kind flu vaccine using mRNA technology - Silicon Valley Moving Post","og_description":"Moderna seeks FDA approval for a new flu vaccine that is made with the same mRNA technology that was key to ending the COVID-19 pandemic.","og_url":"https:\/\/siliconvalleymovingpost.com\/?p=15925","og_site_name":"Silicon Valley Moving Post","article_published_time":"2026-06-18T11:31:43+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/siliconvalleymovingpost.com\/?p=15925#article","isPartOf":{"@id":"https:\/\/siliconvalleymovingpost.com\/?p=15925"},"author":{"name":"admin","@id":"https:\/\/siliconvalleymovingpost.com\/#\/schema\/person\/636e2e5a10a21cf87fe6eb5951e8a6b7"},"headline":"FDA panel considers a first-of-its-kind flu vaccine using mRNA technology","datePublished":"2026-06-18T11:31:43+00:00","mainEntityOfPage":{"@id":"https:\/\/siliconvalleymovingpost.com\/?p=15925"},"wordCount":472,"commentCount":0,"image":{"@id":"https:\/\/siliconvalleymovingpost.com\/?p=15925#primaryimage"},"thumbnailUrl":"https:\/\/siliconvalleymovingpost.com\/wp-content\/uploads\/2026\/06\/96774d3c8a0e0efe3cdbd668c8793d55.webp","articleSection":["Based on facts, either observed and verified directly by the reporter, or reported and verified from knowledgeable sources.","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/siliconvalleymovingpost.com\/?p=15925#respond"]}]},{"@type":"WebPage","@id":"https:\/\/siliconvalleymovingpost.com\/?p=15925","url":"https:\/\/siliconvalleymovingpost.com\/?p=15925","name":"FDA panel considers a first-of-its-kind flu vaccine using mRNA technology - Silicon Valley Moving Post","isPartOf":{"@id":"https:\/\/siliconvalleymovingpost.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/siliconvalleymovingpost.com\/?p=15925#primaryimage"},"image":{"@id":"https:\/\/siliconvalleymovingpost.com\/?p=15925#primaryimage"},"thumbnailUrl":"https:\/\/siliconvalleymovingpost.com\/wp-content\/uploads\/2026\/06\/96774d3c8a0e0efe3cdbd668c8793d55.webp","datePublished":"2026-06-18T11:31:43+00:00","author":{"@id":"https:\/\/siliconvalleymovingpost.com\/#\/schema\/person\/636e2e5a10a21cf87fe6eb5951e8a6b7"},"breadcrumb":{"@id":"https:\/\/siliconvalleymovingpost.com\/?p=15925#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/siliconvalleymovingpost.com\/?p=15925"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/siliconvalleymovingpost.com\/?p=15925#primaryimage","url":"https:\/\/siliconvalleymovingpost.com\/wp-content\/uploads\/2026\/06\/96774d3c8a0e0efe3cdbd668c8793d55.webp","contentUrl":"https:\/\/siliconvalleymovingpost.com\/wp-content\/uploads\/2026\/06\/96774d3c8a0e0efe3cdbd668c8793d55.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/siliconvalleymovingpost.com\/?p=15925#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/siliconvalleymovingpost.com\/"},{"@type":"ListItem","position":2,"name":"FDA panel considers a first-of-its-kind flu vaccine using mRNA technology"}]},{"@type":"WebSite","@id":"https:\/\/siliconvalleymovingpost.com\/#website","url":"https:\/\/siliconvalleymovingpost.com\/","name":"Silicon Valley Moving Post","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/siliconvalleymovingpost.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/siliconvalleymovingpost.com\/#\/schema\/person\/636e2e5a10a21cf87fe6eb5951e8a6b7","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/50b1ad2e498f523425ee0a8cc5180a210646db1622662a3d56cc405d3e0c346a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/50b1ad2e498f523425ee0a8cc5180a210646db1622662a3d56cc405d3e0c346a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/50b1ad2e498f523425ee0a8cc5180a210646db1622662a3d56cc405d3e0c346a?s=96&d=mm&r=g","caption":"admin"},"sameAs":["http:\/\/siliconvalleymovingpost.com"],"url":"https:\/\/siliconvalleymovingpost.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/siliconvalleymovingpost.com\/index.php?rest_route=\/wp\/v2\/posts\/15925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/siliconvalleymovingpost.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/siliconvalleymovingpost.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/siliconvalleymovingpost.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/siliconvalleymovingpost.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15925"}],"version-history":[{"count":0,"href":"https:\/\/siliconvalleymovingpost.com\/index.php?rest_route=\/wp\/v2\/posts\/15925\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/siliconvalleymovingpost.com\/index.php?rest_route=\/wp\/v2\/media\/15924"}],"wp:attachment":[{"href":"https:\/\/siliconvalleymovingpost.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/siliconvalleymovingpost.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/siliconvalleymovingpost.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}